Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Diabetes

Free Subscription 02.03.2026 1 Am J Epidemiol 3 Biochem Biophys Res Commun 1 BMJ 2 Circulation 5 Diabet Med 3 Diabetes 4 Diabetes Care 16 Diabetes Obes Metab 6 Diabetologia 2 Invest Ophthalmol Vis Sci 1 J Am Coll Cardiol 1 J Clin Endocrinol Metab 1 J Diabetes Complications 3 JAMA 1 Med J Aust 1 Metabolism 1 Pediatr Diabetes 11 PLoS One 1 Retina 1 Stroke

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Epidemiol

1. STERN D, Aguilar-Lopez MA, Gomez-Flores-Ramos L, Rodriguez-Ramirez S, et al
   Evaluating the 2023 Mexican Dietary Guidelines for Type 2 Diabetes Prevention: A Target Trial Emulation in Mexican Women.
   Am J Epidemiol. 2026 Feb 23:kwag037. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

2. APTE M, Kumthekar G, Tupe RS
   Connecting glycation and lipotoxicity to mitochondrial dysfunction in diabetic kidney disease: A 'tubulocentric' perspective.
   Biochem Biophys Res Commun. 2026;809:153479.
   PubMed         Abstract available
   
   
3. WEI A, Zhang H, He O, Zhang N, et al
   Identifying a fatty acid metabolic gene signature in diabetic cardiomyopathy through integrated bioinformatics and machine learning.
   Biochem Biophys Res Commun. 2026;809:153485.
   PubMed         Abstract available
   
   
4. LEI Y, Gao C, Zhao X, Kwan Law BY, et al
   KLHL20 alleviates high glucose-induced mitochondrial apoptosis in renal tubular cells by targeting DAPK1 for ubiquitination and degradation.
   Biochem Biophys Res Commun. 2026;805:153345.
   PubMed         Abstract available
   
   

   
   BMJ

5. WISE J
   New weight loss pill outperforms oral semaglutide for diabetes patients, study reports.
   BMJ. 2026;392:s399.
   PubMed        
   
   

   
   Circulation

6. XU Y, Huang T, Zhang Y, Ji D, et al
   Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation.
   Circulation. 2026 Feb 24. doi: 10.1161/CIRCULATIONAHA.125.075157.
   PubMed         Abstract available
   
   
7. HUNDERTMARK MJ, Birkhoelzer SM, Portwood C, Siu AG, et al
   IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes.
   Circulation. 2026;153:550-563.
   PubMed         Abstract available
   
   

   
   Diabet Med

8. PRESS HS, Nicklas L
   How effective are CBT and CBT-based interventions in Type 1 and Type 2 diabetes? An umbrella review.
   Diabet Med. 2026 Feb 20:e70271. doi: 10.1111/dme.70271.
   PubMed         Abstract available
   
   
9. HANLON M, McGuire BE, MacGilchrist C, Kirwan E, et al
   Beyond the wound: A scoping review of the psychosocial impact of diabetes-related foot ulcers.
   Diabet Med. 2026 Feb 20:e70243. doi: 10.1111/dme.70243.
   PubMed         Abstract available
   
   
10. GIBSON R, D'Annibale M, Palla L, Tejo F, et al
    Characterising the impact of shift work on diet and glucose variability in healthcare employees living with type 2 diabetes: The Shift-Diabetes study.
    Diabet Med. 2026 Feb 24:e70262. doi: 10.1111/dme.70262.
    PubMed         Abstract available
    
    
11. DUSATKOVA P, Pavlikova M, Cermakova M, Vesela K, et al
    High prevalence of maturity-onset diabetes of the young in the Czech Republic: A 25-year nationwide registry-based study.
    Diabet Med. 2026 Feb 24:e70279. doi: 10.1111/dme.70279.
    PubMed         Abstract available
    
    
12. ABDEL-MAGID M, Cockcroft EJ, Bright C, Mann RH, et al
    Policy gaps in type 1 diabetes: A UK audit of National Governing Bodies.
    Diabet Med. 2026 Feb 27:e70280. doi: 10.1111/dme.70280.
    PubMed         Abstract available
    
    

    
    Diabetes

13. BONFIELD G, Russ-Silsby J, Ramchand S, Luckett AM, et al
    Biallelic Pathogenic Variants in IL2RA Cause Neonatal-Onset Monogenic Autoimmune Diabetes.
    Diabetes. 2026 Feb 27:db250885. doi: 10.2337/db25-0885.
    PubMed         Abstract available
    
    
14. RAINERI D, Savastio S, Bellone S, Scotti L, et al
    Memory Regulatory T Cells as a Biomarker of Early Type I Diabetes.
    Diabetes. 2026 Feb 23:db250161. doi: 10.2337/db25-0161.
    PubMed         Abstract available
    
    
15. WANG J, Jiang Y, Lv H, Pi D, et al
    Metabolic Signature of Gestational Diabetes Mellitus and Risk of Adverse Birth Outcomes: A Prospective Birth Cohort Study.
    Diabetes. 2026 Feb 20:db250920. doi: 10.2337/db25-0920.
    PubMed         Abstract available
    
    

    
    Diabetes Care

16. ZHAO Y, Xu L, Ren Q, Cheng M, et al
    Reduced Liver Fat Content in GCK-MODY Patients Compared With Healthy Individuals Without Diabetes.
    Diabetes Care. 2026 Feb 24:dc251823. doi: 10.2337/dc25-1823.
    PubMed        
    
    
17. DUMORTIER C, Aho Glele S, Rouland A, Houbachi L, et al
    Effects of Sodium/Glucose Cotransporter-2 Inhibitor Use on Mortality, Amputation, and Healing in Patients With Diabetic Foot Ulcer.
    Diabetes Care. 2026 Feb 25:dc252001. doi: 10.2337/dc25-2001.
    PubMed         Abstract available
    
    
18. GODNEVA A, Phillip M, Segal E, Shilo S, et al
    Investigating the Spectrum of Normoglycemia: Time in Glycemic Ranges and Their Association With Metabolic Outcomes in Individuals Without Diabetes.
    Diabetes Care. 2026 Feb 26:dc252154. doi: 10.2337/dc25-2154.
    PubMed         Abstract available
    
    
19. SHERR JL, Molinsky RL, Pakalapati T, Sherwood JS, et al
    Persistent Burden of Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Among People With Type 1 Diabetes Despite Technology Use: A Follow-up Survey.
    Diabetes Care. 2026 Feb 26:dc252345. doi: 10.2337/dc25-2345.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

20. NAUCK MA, Punov V, Kang YM, Lim S, et al
    Dose-Escalation Regimens for Incretin Mimetics in Type 2 Diabetes Are Associated With Tolerance for Nausea and Vomiting.
    Diabetes Obes Metab. 2026 Feb 27. doi: 10.1111/dom.70613.
    PubMed         Abstract available
    
    
21. MOUNT J, Boye K, Lebrec J, Wilkes E, et al
    Impact of early and tight HbA1c control on the risk of long-term complications and cardiovascular death in patients with type 2 diabetes from the Swedish National Diabetes Register.
    Diabetes Obes Metab. 2026 Feb 27. doi: 10.1111/dom.70584.
    PubMed         Abstract available
    
    
22. HONG JH, Yu SH, Baek KH, Yu J, et al
    Effectiveness and Safety of Evogliptin in Patients With Type 2 Diabetes Mellitus: A Multicenter, Prospective, Observational Study.
    Diabetes Obes Metab. 2026 Feb 26. doi: 10.1111/dom.70601.
    PubMed         Abstract available
    
    
23. IPAYE T, Goldney J, Yates T, Zaccardi F, et al
    Sodium-glucose co-transporter 2 inhibitors and obesity-associated cancers in people with type 2 diabetes: A real-world observational study.
    Diabetes Obes Metab. 2026 Feb 26. doi: 10.1111/dom.70562.
    PubMed         Abstract available
    
    
24. LI Y, Liu W, Wang Y, Wang B, et al
    Rapid improvement of renal microcirculatory homeostasis by liraglutide following diabetes induction.
    Diabetes Obes Metab. 2026 Feb 26. doi: 10.1111/dom.70594.
    PubMed         Abstract available
    
    
25. LIM MY, Lian W, Phua HP, Htun HL, et al
    Visit-to-visit HbA1c variability, risk of all-cause mortality and diabetes-related vascular complications among adult individuals with type 2 diabetes mellitus.
    Diabetes Obes Metab. 2026 Feb 26. doi: 10.1111/dom.70576.
    PubMed         Abstract available
    
    
26. SORENSEN KK, Yazdanfard PDW, Zareini B, Wood-Kurland HK, et al
    Sustained glucagon-like peptide-1 receptor agonist treatment improves glycemic control and reduces all-cause mortality compared to dipeptidyl peptidase-4 inhibitors: A real-world target trial emulation in type 2 diabetes.
    Diabetes Obes Metab. 2026 Feb 25. doi: 10.1111/dom.70581.
    PubMed         Abstract available
    
    
27. ULRICH FS, Frost Nielsen M, Napoli N, Burden AM, et al
    Real-world treatment trajectories preceding GLP-1 receptor agonist initiation in type 2 diabetes: A descriptive UK population-based cohort study on adherence to national clinical guidelines.
    Diabetes Obes Metab. 2026 Feb 25. doi: 10.1111/dom.70548.
    PubMed         Abstract available
    
    
28. SCHMIDT S, Petersen TS, Karstoft K
    Counting days: Cardiovascular and kidney event postponement with glucagon-like peptide 1 receptor agonists in individuals with type 2 diabetes.
    Diabetes Obes Metab. 2026 Feb 24. doi: 10.1111/dom.70589.
    PubMed        
    
    
29. ZHANG Z, Gan L, Camille C, He X, et al
    Mo-Rubbing abdominal improves metabolic homeostasis in type 2 diabetes mellitus mice via a jejunum-specific GLP1-dependent mechanism.
    Diabetes Obes Metab. 2026 Feb 23. doi: 10.1111/dom.70563.
    PubMed         Abstract available
    
    
30. ZHANG Y, Cai Y, Li X, Zhang Q, et al
    Gut microbiota-mediated branched-chain amino acid metabolism: A novel mechanism by which Bacteroides uniformis improves type 2 diabetes mellitus.
    Diabetes Obes Metab. 2026 Feb 23. doi: 10.1111/dom.70559.
    PubMed         Abstract available
    
    
31. DUNN T, Doshi R, Divino V, Chen J, et al
    Real-world predictors of progression to type 2 diabetes among adults with prediabetes.
    Diabetes Obes Metab. 2026 Feb 23. doi: 10.1111/dom.70583.
    PubMed         Abstract available
    
    
32. LADO-ABEAL J, Gude F, Ginzo-Villamayor MJ, Al-Zubaidi K, et al
    Impact of specialised endocrinology care on metabolic control and healthcare utilisation outcomes after kidney transplantation in patients with diabetes: A 12-month observational cohort study.
    Diabetes Obes Metab. 2026 Feb 23. doi: 10.1111/dom.70596.
    PubMed         Abstract available
    
    
33. LEOHR J, Klein O, Heise T, Zijlstra E, et al
    Characterisation of steady-state pharmacokinetics and glucodynamics of once-weekly insulin efsitora alfa in individuals with type 2 diabetes.
    Diabetes Obes Metab. 2026 Feb 23. doi: 10.1111/dom.70585.
    PubMed         Abstract available
    
    
34. MAIER GA, Hennig B, Rathmann W, Kuss O, et al
    Comparative effectiveness of combination therapy with SGLT-2 inhibitors and GLP-1 RAs compared with SGLT-2 inhibitors in individuals with type 2 diabetes: A prevalent new-user cohort study.
    Diabetes Obes Metab. 2026 Feb 22. doi: 10.1111/dom.70523.
    PubMed         Abstract available
    
    
35. LU X, Yuan Z, Lin X, Huang Z, et al
    Association of Elevated Lipoprotein(a) and Diabetes Mellitus With Survival Outcomes in Patients With Coronary Artery Disease: Findings From the CIN-II and RED-CARPET Cohorts.
    Diabetes Obes Metab. 2026 Feb 27. doi: 10.1111/dom.70603.
    PubMed         Abstract available
    
    

    
    Diabetologia

36. LI Z, Liu S, Ho JC, Narayan KMV, et al
    Subtypes of newly diagnosed type 2 diabetes and risk of complications: analysis of electronic health records in the USA.
    Diabetologia. 2026 Feb 21. doi: 10.1007/s00125-026-06687.
    PubMed         Abstract available
    
    
37. FUENTES G, Valero P, Cornejo M, Silva K, et al
    Maternal pre-pregnancy BMI differentially regulates intracellular pH in human umbilical vein endothelium from gestational diabetes mellitus pregnancies, with alkalinisation-associated reduction of adenosine transport in normal weight pregnancies.
    Diabetologia. 2026 Feb 24. doi: 10.1007/s00125-026-06679.
    PubMed         Abstract available
    
    
38. YAN H, Liu J, Zhang Z, Chen S, et al
    Canagliflozin attenuates CMR-quantified myocardial fibrosis in individuals with type 2 diabetes mellitus at high cardiovascular risk: a randomised open-label controlled trial.
    Diabetologia. 2026 Feb 24. doi: 10.1007/s00125-026-06682.
    PubMed         Abstract available
    
    
39. DOBSON JR, Dadi PK, Dickerson MT, Nakhe AY, et al
    The diabetes-associated K(+) channel TALK-2 controls human beta cell endoplasmic reticulum Ca(2+) handling, which promotes basal insulin release and limits glucose-stimulated insulin secretion.
    Diabetologia. 2026 Feb 25. doi: 10.1007/s00125-026-06683.
    PubMed         Abstract available
    
    
40. RUSSON CL, Allen MJ, Cockcroft E, Pemberton JS, et al
    GlucoseGo: a simple tool to predict hypoglycaemia during exercise in type 1 diabetes.
    Diabetologia. 2026 Feb 25. doi: 10.1007/s00125-026-06692.
    PubMed         Abstract available
    
    
41. RISI R, Buzzetti R, Maddaloni E
    Beyond BMI: the need for improved adiposity assessment in studying subclinical cardiovascular autonomic neuropathy in children with type 1 diabetes.
    Diabetologia. 2026 Feb 27. doi: 10.1007/s00125-026-06700.
    PubMed        
    
    

    
    Invest Ophthalmol Vis Sci

42. YU Y, Zhang Y, Tang Y, Ma L, et al
    Advanced Glycation End-Products Contribute to Delayed Diabetic Corneal Epithelial Wound Healing via the TLR4 Signaling.
    Invest Ophthalmol Vis Sci. 2026;67:40.
    PubMed         Abstract available
    
    
43. HUANG L, Liang W, Huma T, Clayton JM, et al
    Ferroptosis: A Novel Mechanism in Diabetic Keratopathy.
    Invest Ophthalmol Vis Sci. 2026;67:41.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

44. AGARWAL R, Green JB, Heerspink HJL, McGill JB, et al
    Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of the CONFIDENCE Randomized Trial.
    J Am Coll Cardiol. 2026;87:772-784.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

45. FLACHS MADSEN LR, Kesmodel US, Kragelund Nielsen K, Damm P, et al
    Gestational diabetes mellitus and risk of selected cancers: a Danish national register-based cohort study.
    J Clin Endocrinol Metab. 2026 Feb 25:dgag068. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

46. HE Y, Gan L, Peng Y, Du W, et al
    Quantitative assessment of structural and functional changes in the carotid artery as vascular markers of gestational diabetes mellitus.
    J Diabetes Complications. 2026;40:109291.
    PubMed         Abstract available
    
    

    
    JAMA

47. ANDERER S
    Maternal Diabetes Associated With Increased Risk of Epilepsy in Children.
    JAMA. 2026 Feb 20. doi: 10.1001/jama.2025.26396.
    PubMed        
    
    
48. LALANI B, Mathioudakis N
    AI-Driven Diabetes Prevention Program-Reply.
    JAMA. 2026 Feb 23. doi: 10.1001/jama.2025.26494.
    PubMed        
    
    
49. ZAVALETA-MONESTEL E, Arguedas-Chacon S
    AI-Driven Diabetes Prevention Program.
    JAMA. 2026 Feb 23. doi: 10.1001/jama.2025.26491.
    PubMed        
    
    

    
    Med J Aust

50. PACIENTE R, Bebbington K, Woolard A, Milroy H, et al
    In the Wake of the National Suicide Prevention Strategy 2025-2035: Suicide Prevention in Type 1 Diabetes.
    Med J Aust. 2026;224:e70156.
    PubMed        
    
    

    
    Metabolism

51. LEE DY, Lee JB, Jung I, Park SY, et al
    Association of daytime circadian-aligned activity with glycemic control in type 2 diabetes: Insights from continuous glucose monitoring and wearable data.
    Metabolism. 2026;179:156570.
    PubMed         Abstract available
    
    

    
    Pediatr Diabetes

52. LUO J, Li Q, Gao Y, Liu F, et al
    The Mediating Effects of Diabetes Self-Management on the Relationship Between Diabetes Distress and Quality of Life Among School-Age Children With Type 1 Diabetes Mellitus During the COVID-19 Pandemic.
    Pediatr Diabetes. 2026;2026:2022750.
    PubMed         Abstract available
    
    

    
    PLoS One

53. BUI L, Le TT, Dao NH, Nguyen HT, et al
    Statin prescribing patterns in cardiovascular risk management among outpatients with type 2 diabetes: Real-world practices at a Vietnamese general hospital.
    PLoS One. 2026;21:e0343313.
    PubMed         Abstract available
    
    
54. GHOTBI AB, Khoshparast B, Hekmat H, Shahali Z, et al
    Antibiotic consumption and medication cost in diabetic patients: Insights from Iran health insurance organization (IHIO) claims data.
    PLoS One. 2026;21:e0343090.
    PubMed         Abstract available
    
    
55. HAJIUNI K, Salehi S, Rajabli Z, Azadnajafabad S, et al
    Prevalence and factors associated with comorbidities in Iranian patients with type 2 diabetes: A national study.
    PLoS One. 2026;21:e0343690.
    PubMed         Abstract available
    
    
56. ZENGIN E, Ucgun A, Cevik ME, Evrimler S, et al
    The association between epicardial adipose tissue thickness and diabetes mellitus, hyperlipidemia, hepatosteatosis, pancreatic steatosis and pancreatitis.
    PLoS One. 2026;21:e0343831.
    PubMed         Abstract available
    
    
57. LIU S, Ma L, Niu Y, Ma R, et al
    Sex-specific association of visceral adiposity index with renal dysfunction in chinese type 2 diabetes: A cross-sectional study.
    PLoS One. 2026;21:e0343375.
    PubMed         Abstract available
    
    
58. SUWANNAKHAN A, Khamsai S, Pratipanawatr T, Kirisattayakul W, et al
    Ultrasound assessment of tibial nerve cross-sectional area in diabetic peripheral neuropathy in the Thai Population.
    PLoS One. 2026;21:e0343128.
    PubMed         Abstract available
    
    
59. KHOSRAVI Z, Barzinpour F, Rabizadeh S, Nakhjavani M, et al
    Machine learning prediction of metabolic-associated fatty liver disease in type 2 diabetes: Emphasizing data imputation and feature selection.
    PLoS One. 2026;21:e0339580.
    PubMed         Abstract available
    
    
60. SUKKARIEH O, Egede L, Osman M, Bassil M, et al
    Reimagined diabetic care approach: A qualitative study on the acceptability of mhealth interventions in a LMIC.
    PLoS One. 2026;21:e0343711.
    PubMed         Abstract available
    
    
61. CAO J, Dong F, Li X, Zhu X, et al
    Integrated bioinformatics-based identification of proliferative diabetic retinopathy and idiopathic pulmonary fibrosis: Focus on fibrosis and immune infiltration.
    PLoS One. 2026;21:e0343398.
    PubMed         Abstract available
    
    
62. THOMSON AM, Drost DC, Johannsen NM, Silvestri C, et al
    Understanding the gut microbiome through a fitness intervention of aerobic and resistance training for individuals with type 2 diabetes mellitus (GUTFIT: A Study Protocol).
    PLoS One. 2026;21:e0343294.
    PubMed         Abstract available
    
    
63. SWOLIN-EIDE D, Pundziute Lycka A, Forsander G, Novak D, et al
    Independent validation of circulating microRNAs as biomarkers in a case-control study of adolescents with type 1 diabetes for more than 8 years.
    PLoS One. 2026;21:e0343117.
    PubMed         Abstract available
    
    

    
    Retina

64. SCAMPOLI A, Governatori L, Solimeo A, Plaitano C, et al
    Association Between Baseline Glycated Hemoglobin Levels and Functional and Anatomical Outcomes Following Faricimab Loading Phase in Diabetic Macular Edema.
    Retina. 2026 Feb 24. doi: 10.1097/IAE.0000000000004820.
    PubMed         Abstract available
    
    

    
    Stroke

65. FEGHALI J, Ruchika F, Horowitz MA, Xu R, et al
    Glucagon-Like Peptide-1 Receptor Agonists and Decreased Subarachnoid Hemorrhage Risk in Patients With Intracranial Aneurysm.
    Stroke. 2026 Jan 6. doi: 10.1161/STROKEAHA.125.053599.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum